In conjunction with the studies, which demonstrate the role of ERBB3 on metastasis of ovarian cancer, another study using immunohistochemical analysis identified that high levels of ERBB3 are associated with poor outcome in ovarian cancer patients [13]. This evidence concerns the gene ERBB3 and ovarian cancer.